World Cancer Day 2021: Cromos Pharma is committed to supporting clinical research to make cancer breakthroughs
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer.
It promotes better understanding of cancer and highlights risk factors and ways in which we can all reduce our chances of certain cancers. It advocates for continued clinical research into cancers and effective therapies and treatments.
Global Cancer Stats:
- In 2020, 19.3 million new cases of cancer were diagnosed worldwide
- Cancer is the second leading cause of death accounting for almost 10 million deaths in 2020.
- Breast and lung cancers are the most common making up 11.7% and 11.4% of all new case diagnosed in 2020.
Source: The Global Cancer Observatory
Cromos Pharma’s commitment to cancer clinical research
At Cromos Pharma we are proud to play our part by supporting our clients in developing novel and innovative treatments for a wide range of cancers.
Since 2004, we have been providing offering fully integrated clinical research services delivering all aspects of clinical trials in all clinical phases. Our very first research project was in oncology and since then we have been supporting our clients in cancer clinical research. We have successfully managed hundreds of studies ranging from innovative treatments to cost-advantaged generic and biosimilar therapies, from targeted therapies to companion treatments to help cancer patients withstand the rigors of chemotherapy and radiation.
We remain committed to this work and to accelerating the development of cancer treatments to reduce mortality and help improve the lives of all of those living with cancer worldwide.
Read more about World Cancer Day here www.worldcancerday.org